FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Apraclonidine (IOPIDINE) Ophthalmic Solution
Status: Discontinuation
»Therapeutic Categories: Ophthalmology

Expand all

Novartis (New 09/21/2018)

Company Contact Information:
888-669-6682

Presentation Posting Date Related Information
IOPIDINE® (apraclonidine hydrochloride) 0.5% Ophthalmic Solution 5mL in 1 Bottle (NDC 0065-0665-05) 09/21/2018 Novartis Pharmaceuticals has made a business decision to permanently discontinue the product Iopidine Solution 0.5%, 5mL and 10mL.
IOPIDINE® (apraclonidine hydrochloride) 0.5% Ophthalmic Solution 10mL in 1 Bottle (NDC 0065-0665-10) 09/21/2018 Novartis Pharmaceuticals has made a business decision to permanently discontinue the product Iopidine Solution 0.5%, 5mL and 10mL.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English